APOC3 and atherosclerosis: The apo C-III containing lipoproteins are hypothesized to promote atherosclerosis by activating circulating monocytes to adhere to vascular endothelial cells [15] and altering LDL composition to promote LDL adhesion to the subendothelial extracellular matrix [16].